Israel Business Currents
SEE OTHER BRANDS

Fresh news on business and economy in Israel

Israel Business Currents: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Israel Business Currents.

Press releases published on May 15, 2025

YouTube Presents Gold Creator Award To Cybercrime Magazine For Surpassing 1 Million Subscribers

YouTube Presents Gold Creator Award To Cybercrime Magazine For Surpassing 1 Million Subscribers

Cybercrime Magazine YouTube Channel for Boardroom …

Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy

Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy

TEL AVIV, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Moody's Investor Services (“Moody's”) has raised the company's corporate credit rating to Ba1, outlook stable; from Ba2, outlook positive. …

REE Automotive Announces Fourth Quarter and Fiscal Year 2024 Earnings Results

REE Automotive Announces Fourth Quarter and Fiscal Year 2024 Earnings Results

TEL AVIV, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- REE Automotive Ltd. (Nasdaq: REE) (“REE” or the “Company”), an automotive technology company that develops and builds software-defined vehicle technology and a provider of full by-wire electric trucks and …

Pluri CEO Issues Shareholder Letter Highlighting Strategic Growth, Innovation, and Global Market Expansion

Pluri CEO Issues Shareholder Letter Highlighting Strategic Growth, Innovation, and Global Market Expansion

Major milestones include entry into cultivated cacao and coffee markets and progress toward commercial-scale production Company reports nearly 400% revenue growth in the first nine months of fiscal year 2025 compared to the same period in fiscal year 2024, …

BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates

BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates

In March 2025, BiomX announced positive topline results of the phase 2 trial evaluating BX211 for the treatment of diabetic foot osteomyelitis (DFO) BX004 Phase 2b study in Cystic Fibrosis (CF) on track to report topline results in Q1 2026 In April 2025, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service